Health

The 2025 BPD Singapore Conference Has Concluded Successfully! Jointly Embarking on a New Journey for Global Development

SINGAPORE, Sept. 26, 2025 /PRNewswire/ -- The 2025 BPD (Biopharmaceutical Bioprocess Development) Singapore Summit, which co-hosted by WuXi XDC (Stock Code: 2268.HK), was successfully concluded fromSeptember 24-26, 2025. The conference brought together leading biopharmaceutical companies and rese...

2025-09-27 10:45 3608

Datasea Reports Record Fiscal Year 2025 Revenue of $71.62 Million, Up 199% Year-over-Year

DTSS Achieves Fourth Quarter Net Income Breakeven Driven by Cutting-Edge Acoustics and AI Multimodal Digitalization;  Ongoing Commercialization Updates in the Coming Weeks BEIJING, Sept. 26, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada-based high-tech ente...

2025-09-26 21:30 4693

NYSE Content Advisory: Pre-Market Update + Wall Street digests August PCE data

NEW YORK, Sept. 26, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + Wall Street digests ...

2025-09-26 21:28 3831

COREE Announces Discovery of Microbiome Biomarkers Specific to Diabetes and Obesity Patients

* Joint research achievement by Gemelli Hospital in Rome, COREE, COREE Pohang, and the Università Cattolica del Sacro Cuore SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- COREE announced on September 15 that it had, for the first time in the world, identified microbiome biomarkers specific...

2025-09-26 21:00 2367

Concord Medical Reports Financial Results for the First Half of 2025

BEIJING, Sept. 26, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced its unaudited consolidated financial results for t...

2025-09-26 19:30 3215

Asia Pacific Enterprise Awards (APEA) 2025 Taiwan Honors Outstanding Leaders and Enterprises Shaping the Future of Business

TAIPEI, Sept. 26, 2025 /PRNewswire/ -- The Asia Pacific Enterprise Awards (APEA) recently celebratedTaiwan's visionary leaders and pioneering enterprises that are reshaping industries and championing sustainable growth. Organized by leading regional NGO Enterprise Asia, the prestigious Taiwan Cha...

2025-09-26 18:16 2232

Tescan acquires FemtoInnovations and launches Laser Technology Business Unit

TAIPEI, Sept. 26, 2025 /PRNewswire/ -- Tescan Group today announced the acquisition ofFemtoInnovations, a leading innovator in ultrafast laser technologies, and the creation of a dedicatedLaser Technology Business Unit (LT BU) headquartered at the University of Connecticut (UConn) Tech Park. The ...

2025-09-26 14:47 2247

CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy

FILSPARI® (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss ST. GALLEN, Switzerland, and SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical...

2025-09-26 14:30 1469

Get Race-Ready for KLSCM 2025 with Pantai Hospital Kuala Lumpur

A Hospital That Runs With You KUALA LUMPUR, Malaysia, Sept. 26, 2025 /PRNewswire/ -- As the countdown begins to the Kuala Lumpur Standard Chartered Marathon (KLSCM) 2025, thousands of runners are training hard to hit their personal bests. But while most are focused on mileage, timing, and gear, ...

2025-09-26 13:51 2260

Tourism Malaysia and MHTC Bring Malaysia Fair 2025 to Surabaya A Celebration of Culture, Cuisine, Travel, and Healthcare Excellence

SURABAYA, Indonesia, Sept. 26, 2025 /PRNewswire/ -- Tourism Malaysia, in collaboration with the Malaysia Healthcare Travel Council (MHTC), proudly presents Malaysia Fair 2025—a four-day celebration ofMalaysia's culture, cuisine, tourism, and healthcare excellence. Taking place at Pakuwon Mall, Su...

2025-09-26 09:45 2467

Catalent Announces Opening of its New Global Corporate Headquarters in Tampa, Florida

Relocation reflects a strategic expansion in Florida alongside long-standing manufacturing facility in nearby St. Petersburg New headquarters designed to support innovation, collaboration and growth TAMPA, Fla., Sept. 26, 2025 /PRNewswire/ -- Catalent, Inc., the leader in enabling the developmen...

2025-09-26 09:00 1675

Jacobio Chairman and Concerted Parties Increase Shareholding by Nearly HK$100 Million, Demonstrating Confidence in Long-term Growth

BEIJING, SHANGHAI and BOSTON, Sept. 25, 2025 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK)today announced that its Chairman and Chief Executive Officer, Dr. Yinxiang Wang, together with concerted parties, have recently increased their shareholding in the Company by 11.06 million shares, repr...

2025-09-26 08:47 1591

Building a National Lung Cancer Screening Model with AI: Early Lessons from Australia

BRISBANE, Australia and SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- Coreline Soft announced today it will host an international webinar on Tuesday, October 14, sharing firsthand experiences and insights fro...

2025-09-26 07:00 1732

Bambusa Therapeutics Announces Highly Positive Healthy Volunteer Results and First Atopic Dermatitis Patient Dosed in Phase I Trial of BBT001

BOSTON, Sept. 25, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Bambusa Therapeutics), a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology and inflammation, today announced two landmark achievements for its lead program, BBT001. Last week, Ba...

2025-09-25 22:04 1726

The FDA Granted Orphan Drug Designation to Biostar Pharma's Utidelone for the Treatment of Pancreatic Cancer

SAN FRANCISCO, Sept. 25, 2025 /PRNewswire/ -- Biostar Pharma, Inc., the US wholly-owned subsidiary of Beijing Biostar Biopharmaceutical Co., Ltd. ("Biostar," stock code: 2563.HK) which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of ...

2025-09-25 21:37 1845

Flat Medical Establishes Clinical Advisory Board for Pain Interventions, Names Dr. Krishnan Chakravarthy as Chairman

AUSTIN, Texas, Sept. 25, 2025 /PRNewswire/ -- Flat Medical, a leading innovator in medical device solutions, today announced the formation of itsClinical Advisory Board for Chronic Pain Interventions and the appointment of Dr. Krishnan Chakravarthy, MD, PhD, as its inaugural Chairman. This strate...

2025-09-25 21:00 1570

iotaMotion Surpasses 1,000 Clinical Procedures Performed with iotaSOFT® --Defining a New Era in Cochlear Implant Surgery

* Fewer than 5% of eligible patients worldwide receive cochlear implants today * Hearing loss is the largest modifiable risk factor for dementia, linked to approximately 8% of global cases — more than hypertension, obesity, smoking, or depression ST. PAUL, Minn., Sept. 25, 2025 /PRNewswire/ -- ...

2025-09-25 20:33 1360

WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™,to Accelerate Biologics Development with High Titer and Superior Stability

* TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone screening and guarantees expression stability. * The platform has achieved an average mAb titer exceeding 8.0 g/L with over 99% of clonal cell lines maintaining sta...

2025-09-25 19:42 1573

Waterdrop Inc. Published 2024 ESG Report: Expanding Support to Vulnerable Groups, Providing Rural Medical Clinic Access to Over 500 Thousand Beneficiaries

BEIJING, Sept. 25, 2025 /PRNewswire/ -- On September 25th, Waterdrop Inc. released its2024 Environmental, Social and Governance (ESG) Report (hereinafter "the Report"), which offers an in-depth overview of the Company's progress and initiatives in corporate governance, technology innovation, prod...

2025-09-25 13:09 3138

C2F Empowers Chula to Advance Academic Excellence and Research on the Path to Becoming a World-Class University

BANGKOK, Sept. 25, 2025 /PRNewswire/ -- The C2F, or Second Century Fund , of Chulalongkorn University supports research that addresses social, environmental, economic, and national policy challenges. In 2025, over 1,000 scholarships will be awarded, with nearly700 millio...

2025-09-25 10:00 1584
1 ... 40414243444546 ... 874

Week's Top Stories